151 related articles for article (PubMed ID: 19553756)
1. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
Yilmaz Y; Ongen Z
Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
[TBL] [Abstract][Full Text] [Related]
2. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
Koenig W
Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
[TBL] [Abstract][Full Text] [Related]
3. [C-reactive protein in cardiovascular diseases].
Lubas W; Gutkowski K
Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810
[TBL] [Abstract][Full Text] [Related]
4. [C-reactive protein in cardiovascular risk evaluation].
Fabijanić D; Banić M; Kardum D
Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
Li JJ; Fang CH
Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
Koenig W
Ital Heart J; 2001 Mar; 2(3):157-63. PubMed ID: 11305526
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein: a novel marker of cardiovascular risk.
Shah SH; Newby LK
Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
[TBL] [Abstract][Full Text] [Related]
8. [C-reactive protein potential risk factor for cardiovascular disease].
Tornvall P; Pernow J; Hansson LO
Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
[TBL] [Abstract][Full Text] [Related]
9. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
Mitra B; Panja M
J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
[TBL] [Abstract][Full Text] [Related]
10. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
Genest J
Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
[TBL] [Abstract][Full Text] [Related]
11. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
12. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and coronary heart disease.
Foody JM; Gotto AM; Wenger N
N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
[No Abstract] [Full Text] [Related]
15. C-reactive protein: a new golden marker of cardiovascular risk.
Gomes MC
Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
[TBL] [Abstract][Full Text] [Related]
16. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.
Abdelmouttaleb I; Danchin N; Ilardo C; Aimone-Gastin I; Angioï M; Lozniewski A; Loubinoux J; Le Faou A; Guéant JL
Am Heart J; 1999 Feb; 137(2):346-51. PubMed ID: 9924170
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
18. [C-reactive protein in coronary disease--pathogenic factor or marker of the disease].
Goch JH; Sadurska J
Pol Merkur Lekarski; 2002 Jul; 13(73):70-3. PubMed ID: 12362513
[TBL] [Abstract][Full Text] [Related]
19. [C-reactive protein: cardiovascular issues of an acute-phase protein].
Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
[TBL] [Abstract][Full Text] [Related]
20. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
